Genome & Company (KOSDAQ: 314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,770.00
-125.00 (-4.32%)
Dec 19, 2024, 2:34 PM KST

Genome & Company Revenue

Genome & Company had revenue of 4.62B KRW in the quarter ending September 30, 2024, with 3.70% growth. This brings the company's revenue in the last twelve months to 24.09B, up 65.54% year-over-year. In the year 2023, Genome & Company had annual revenue of 14.30B with 1.50% growth.

Revenue (ttm)
24.09B
Revenue Growth
+65.54%
P/S Ratio
2.30
Revenue / Employee
240.90M
Employees
100
Market Cap
82.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.30B211.39M1.50%
Dec 31, 202214.08B13.63B3,021.27%
Dec 31, 2021451.25M300.66M199.67%
Dec 31, 2020150.58M104.75M228.54%
Dec 31, 201945.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition